Literature DB >> 35434312

Anatomical and audiological considerations in branchiootorenal syndrome: A systematic review.

Kirsty Biggs1,2, Gemma Crundwell3, Christopher Metcalfe1,4, Jameel Muzaffar4,5, Peter Monksfield4, Manohar Bance3,5.   

Abstract

Objective: Establish anatomical considerations, audiological outcomes, and optimal management in patients with branchiootic/branchiootorenal syndrome (BO/BOR).
Methods: Databases reviewed: Medline, Pubmed, Embase, Web of Science, Cochrane Collection, and ClinicalTrials.gov. Clinical or radiological studies of patients with BOR syndrome describing either the audiological profile or anatomical changes were included. Articles in which BOR syndrome was associated with other syndromes, and those that were focused only on general and genetic aspects of BOR syndrome were excluded. Articles were assessed using Oxford Centre for Evidence-Based Medicine (OCEBM) grading system and the Brazzelli risk of bias tool for nonrandomized studies.
Results: Searches identified 379 articles. Of these, 64 studies met the inclusion criteria, reporting outcomes in 482 patients from at least 95 families. In 308 patients, hearing loss was categorized as sensorineural (29%), conductive (20%), and mixed (51%). Hearing outcomes were variable in terms of onset, pattern, and severity; ranging from mild to profound deafness. One hundred sixty-nine patients presented with inner ear anomalies, 145 had middle, and 151 had external ear abnormalities. In 44 studies, 58 ear operations were described. Mixed outcomes were reported in patients managed with hearing aids or middle ear surgery; however, successful cochlear implantation was described in all five cases.
Conclusion: The anatomical and audiological profiles of patients with BO/BOR are variable. A range of surgical procedures were described, however lacked objective outcome measures. Given the range of anatomical variants, management decisions should be made on an individual basis including full audiological and radiological assessment. Level of evidence: NA.
© 2022 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.

Entities:  

Keywords:  audiology; branchiootorenal syndrome; otology/neurotology; systematic review

Year:  2022        PMID: 35434312      PMCID: PMC9008175          DOI: 10.1002/lio2.749

Source DB:  PubMed          Journal:  Laryngoscope Investig Otolaryngol        ISSN: 2378-8038


INTRODUCTION

Branchiootorenal (BOR) syndrome is a rare autosomal dominant condition, first described by Melnick et al. in 1975. BOR is also referred to as Melnick‐Fraser syndrome and branchiootic syndrome (BO). It accounts for 2% of childhood inner‐ear deafness, affecting one in 40,000. The clinical features of BOR are variable. Chang et al. developed diagnostic criteria to including major and minor phenotypic features (Table 1). Major criteria included branchial anomalies, deafness, preauricular pits, or renal anomalies and minor criteria included inner, middle, and external ear anomalies, preauricular tags, facial asymmetry, and palatine abnormalities. Chen et al. considered anomalies affecting over 20% of patients to be common; these included hearing loss, preauricular pits or tags, renal anomalies, branchial fistulae, pinnae deformities, and external auditory canal stenoses. Other clinical features described in BOR include otitis media, facial abnormalities, lacrimal dysfunction, and abnormalities of the bladder and ureters and gastrointestinal system. Fraser et al. reported a range of hearing impairments, including conductive, sensorineural, and mixed loss from a young age. An audiological literature review by Lindau et al., determined mixed loss to be the most common type of hearing impairment with variability in type, degree and progression of hearing loss. Stenosis and atresia of the external auditory canal, and pinnae deformities are the most common external ear anomalies. Malformations of the ossicles and middle ear cavity have been described, alongside inner ear abnormalities, including cochlear hypoplasia and an enlarged vestibular aqueduct. CT scanning has proven to be particularly useful at identifying temporal bone abnormalities. Propst et al. reported the most common characteristics identified on CT as, hypoplastic apical turn of the cochlea (incomplete partition type II or “Mondini dysplasia”), a facial nerve medial to the cochlea, funnel‐shaped internal auditory canal, and a patulous eustachian tube. The presence of an “unwound cochlea” on CT has also been reported specifically in patients with BOR; typically featuring hypoplastic middle and apical turns anteriorly offset away from a tapered basal turn. , When compared to controls, patients with BOR had significant anatomical differences including an underdeveloped mastoid tip, low tegmen, and a higher frequency of nonpneumatization in the mastoid cortex and facial recess.
TABLE 1

Diagnostic criteria

Diagnostic criteria for BOR syndrome a (Chang et al.)
Major criteriaMinor criteria
Branchial anomaliesExternal ear anomalies
DeafnessMiddle ear anomalies
Preauricular pitsInner ear anomalies
Renal anomaliesPreauricular tags
Other: facial asymmetry, palate abnormalities

All affected individual must have at least three major criteria; two major criteria and at least two minor criteria, or one major and an affected first‐degree relative meeting criteria for BOR.

Diagnostic criteria All affected individual must have at least three major criteria; two major criteria and at least two minor criteria, or one major and an affected first‐degree relative meeting criteria for BOR. The EYA1 gene (homolog of the Drosophila eyes absent gene) was first identified to underlie BOR syndrome in 1997. It is located in the chromosomal region 8q13.3 and accounts for approximately 40% of cases. Over 80 different EYA1 mutations are reported; however, no correlation with phenotypic presentation has been identified. , Less commonly, SIX1, SIX5, and SALL1 genes have been implicated, with an unidentified genotype in approximately half of all BOR cases. , , Given the clinical and genetic heterogeneity, diagnosis of BOR is challenging and it has been referred to as “spectrum disorder”. , Chang et al. proposed phenotypic criteria to determine which patients should undergo genetic investigation (Table 1). Patients qualified for EYA1 genetic analysis if they had either; three of the four major criteria (branchial anomalies, deafness, preauricular pits, or renal anomalies), two major and two minor characteristics, or one major if their first‐degree relative was also affected. Hsu et al. suggest radiologic criteria, such as the “unwound cochlea” and medialized facial nerve are specific for BOR, and could be used to stratify for genetic studies in sensorineural hearing loss. This systematic review and narrative synthesis aims to establish anatomical considerations, audiological outcomes and optimal management in patients BO/BOR. Population: Adults or children with BO/BOR. Intervention: Surgical procedures of the internal, middle, or external ear, including cochlear implantation (CI). Comparison: Other method of hearing rehabilitation or repeated measures within the same patients. Outcomes: Audiometric outcomes, whether objective or subjective.

METHODS

This study is a systematic review and narrative synthesis conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines (PRISMA) guidelines. A protocol was written however it was not formally registered with PROSPERO

Inclusion and exclusion criteria

Clinical or radiological studies of patients with BOR syndrome describing either the audiological profile or anatomical changes in patients with BOR syndrome were included. Exclusion criteria was based on the methods described by Lindau et al. in their audiological review of BOR syndrome. This review used the following criteria for the exclusion of articles: the title and summary were not related to the purpose of the review, duplicated articles, animal studies, articles written in languages other than English, editorial letters, conference abstracts, book chapters, review articles, articles in which BOR syndrome was associated with other syndromes, articles that cited BOR syndrome as a cause of loss of hearing, and those that were focused only on general and genetic aspects of BOR syndrome.

Search strategy

Two reviewers (KB/GC) independently performed the searches and screened the abstracts. The following databases were searched: MEDLINE, PubMed, EMBASE, Web of Science, Cochrane Collection, and ClinicalTrials.gov (via Cochrane). The search terms used were as follows: “Branchio‐Oto‐Renal” “Branchio‐Otic” BOR Melnick‐Fraser 1 OR 2 OR 3 OR 4 “Hearing loss” “hearing disorders” Audiolog* 6 OR 7 OR 8 5 AND 9

Selection of studies

Searches were performed by an Information Specialist Librarian (Matthew Stone). The two reviewers (KB/GC) independently screened all the records by title and abstract identified from the database searches. Studies describing audiological findings or ear anatomy in patients with BOR syndrome were assessed against the inclusion and exclusion criteria, with any disagreement resolved by discussion with a third reviewer (CM/JM). Studies without accessible abstract or full text after the title/abstract screening were followed up by attempting to contact the respective study authors. If they remained unavailable, the study was excluded. Studies that described either audiological or anatomical features of BO/BOR were included. Most studies (case series) were only descriptive, with no detail provided on clinical intervention. In studies including surgical or hearing rehabilitation, all described audiological outcomes were recorded. Some noninterventional studies, focused on temporal bone imaging, presented anatomical findings only.

Data extraction

Data were extracted by the first reviewer (KB) and then checked by a second reviewer (GC). Data was extracted on patient age and sex, the type, degree, onset and pattern of their hearing loss, features of BOR syndrome, genetics, ear anatomy, hearing interventions and the outcomes of the intervention. Extracted data were arranged and percentages were calculated in a spreadsheet (Excel, Microsoft Corp.).

Risk of bias quality scoring

The two reviewers independently assessed the risk of bias using the Brazzelli risk of bias tool for nonrandomized studies. Studies were also graded according to the Oxford Centre for Evidence‐Based Medicine (OCEBM) grading system. Discrepancies between the reviewers were resolved by discussion.

RESULTS

Searches were initially performed on August 25, 2020, and rechecked on October 11, 2020. A flowsheet detailing the study selection according to the PRISMA is included in Figure 1.
FIGURE 1

PRISMA flow diagram

PRISMA flow diagram

Description of Studies

A total of 64 studies met the inclusion criteria with a total of 482 patients from at least 95 different family groups. There were 39 case series, 21 single‐case studies, 3 case–control studies, and 1 cross‐sectional study. All studies were published between 1976 and 2020. A total of 17 studies included pediatric patients only, 29 studies included both adults and children, 11 studies included adults only, and data were missing in 7 studies. The age of subjects ranged from 0 to 79 years, and 53% (175/331) of subjects were female. Data on patients' sex were missing for 151 cases. Genetic testing demonstrated 190 (39%) patients to be positive for EYA1 mutations or linkage, 21 (4%) patients with SIX1 mutations, , , , two patients (<1%) with a SALL1 mutation and one 22q partial tetrasomy. Study characteristics are summarized in Table 2.
TABLE 2

Summary of audiological outcomes, anatomical findings, and interventions

AuthorSampleType of hearing lossAgeDegreePatternEar anatomyInterventionOutcomes
1Melnick et al n = 4 (two generations)MixedFather = 44 years, children unknownVariablexMD, stapes fixation, cup‐shaped pinnae1 = HA, auricular surgeryDifficulty in communicating despite HA (n = 1)
2Fraser et al n = 8 (three generations)Mixed, conductive, SN11 months–40 yearsMild–severeProgressiveME fluid, otosclerosis, ossicle hypoplasia and OC displacement, OM, protuberant auricles, cochlear hypoplasiaCase 1: myringotomies(B/L) for recurrent OM, HA and rehabilitation. Case 2: repeated stapedectomies4× unsuccessful stapedectomies (n = 1), hearing aids unsuccessful (n = 1)
3Cremers et al n = 19 (four families)Mixed, conductivexxxCochlear hypoplasia/dysplasia, narrow or wide IAC, OC anomalies (not specified), SC (horizontal)hypoplasia, anomalous pinnaExploratory tympanotomy in 6 patients (7 ears), Teflon interposition attempted in 3 patientsMiddle ear surgery feasibly impractical to attempt (n = 4), Teflon interposition unsuccessful (n = 3)
4Smith et al n = 3 (two generations)Mixed, conductive4–26 yearsMild–severeProgressive, stableRecurrent OM, fused incudomalleolar complex, absence of stapes and long process of the incus, cup‐shaped pinnaeCase 1: myringotomies with grommet insertion (B/L), exploratory tympanotomy and ossicular reconstruction with total ossicular replacement prosthesis. Case 2: myringotomies with grommet insertion (B/L)Case 1: Persistent conductive loss after myringotomies, postossicular reconstruction: mild–moderate conductive loss on PTA, speech reception threshold: Right 88%, 35 dB; Left 88%, 30 dB. Case 2: interval PTA: mild low‐frequency conductive loss, speech reception threshold: Right, 88%, 10 dB; Left, 88%, 20 dB, being evaluated for HA
5Slack et al n = 12 (four families)Mixed, SN6 months–26 yearsSevereStableMonopodal stapes, abnormal malleus and incus, IAC bulbous, cochlear hypoplasia with reduced turns, short and wide SC (lateral), lop earsExploratory tympanotomies in 2 cases, stapes reconstruction with interposed homograft incus between malleus handle and oval windowNo improvement in hearing (numbers not included in paper)
6Gimsing et al n = 17 (three families)Mixed, conductive, SN7–48 yearsMild–severeProductive, stableMalformed incus, absent stapes and oval window, under developed middle cavity, cochlear hypoplasia, cup‐shaped pinnae, microtiaCase 1: malformed incus replaced with homograft prosthesis. Case 2: non‐specified middle ear surgery (severely malformed)Case 1: postoperative improvement in air bone gap below 2000 Hz, unchanged at higher frequencies. Case 2: air conduction threshold improved only 20 dB.
7Lipkin et al n = 2 (two generations)SN5 and 31 yearsMild–severeStableCongenital cholesteatoma filling the sinus tympani, facial recess and ME, displaced ossiclesFirstt procedure: ME exploration and removal of a cholesteatoma, second procedure (1 year later): ossicular reconstruction with ceramic total ossicular replacement prosthesis.No recurrence of cholesteatoma seen at second surgery
8Martini et al n = 8Mixed, conductive, SN4‐year‐adultMild–severexDisplaced OC, abnormal SC, labyrinth and cochlear hypoplasia with absent basal turn, cup‐shaped pinnaeExploratory tympanotomyx
9Ostri et al n = 19 (four generations)MixedxModerate–severeStableCochlear and SC hypoplasia, massive OC and reduced size of ME, auricular anomaliesHA in 16 casesx
10Dagglias et al n = 1X2.5 yearsSeverexEAC stenosis, bilateral ossicular mass fixation, malformed incus, B/L cochlear hypoplasia, dilated vestibules, SC (horizontal) hypoplasia, EED, IAC short and wide, cup‐shaped pinnaeHANormal speech
11Cremers et al n = 3 (one family)Mixed, conductive16 yearsMild–severexCurved EAC, no pneumatization of mastoid, absent stapes footplate and long process incus, nonmobile malleus, pinna dysplasiaTwo operations: auricle reconstruction, and exploratory tympanotomy and mastoidectomy with creation of neo‐oval windowSignificant hearing improvement at 2 yr follow‐up (55 dB to 15 dB PTA air bone gap closure), no complications
12König et al n = 3MixedxSeverexSmall incus and a very large antrumxx
13Chen et al n = 32Mixed, conductive, SNxMild–profoundProductive, stableStenosis of the EAC, malformation of OC, cochlear hypoplasia/dysplasia, EED, lop ear deformityxx
14Millman et al n = 1x6 monthsSeverexNormal otoscopyxx
15Misra et al n = 1Mixed44 yearsModerate–severexDisplaced and misshapen ossicles, facial nerve anomalyHA (B/L) from childhood, 2 surgeries to left ear (age 27 and 33), followed by radical tympanomastoidectomy with facial nerve decompressionx
16Graham et al n = 2 (one family)Mixed, conductive14 months, 36 yearsModerateStableCholesteatoma, absence/abnormality of the ossicles and oval window, lateralization of the malleus‐incus complex and the absence of contact with the stapes, facial nerve anomaliesMother: HA + left exploratory tympanotomy age 16, infant: HA + surgical removal cholesteatoma at 10 monthsInfant: inadequate postoperative healing and infection of mastoid process (requiring IV antibiotics) after successful cholesteotoma removal, with 3× OM episodes
17Weber et al n = 6Conductive, SNnewborn to 33 yearsMild–moderatexCup‐shaped pinnaxx
18Worley e tal n = 1Mixed3 yearsModerateStableCholesteatoma (B/L) OME and loss of ventilation tubes, deformed ME cavity (B/L), malformed ossicles with fused malleus and incus, SC and cochlear hypoplasia, microtiaGrommets inserted, HA (B/L), radical mastoidectomy w/o reconstruction, stenting of stenosed meatus requiredFacial nerve function preserved postoperatively, manages well with HA (B/L). She attends a mainstream school with input from a teacher for the deaf
19Prabhu et al n = 1Mixed12 yearsxxPinna dysplasia (unilateral)xx
20Usami et al n = 3 (two generations)Mixed, conductivexMild–severeStableCochlear and SC (lateral and posterior) hypoplasia (B/L), displaced OC, congenital cholesteatoma, cup‐shaped pinnaeExploratory tympanotomyx
21Bamiou et al n = 3SNxxxMDxx
22Kemperman et al n = 2 (one family)Mixed, SN55 and 30 yearsProfoundProgressive, fluctuantSon: Abnormal configuration of OC, dysplastic long process of incus, incomplete stapedial crura, MD, wide IAC, plump vestibule, EVA, recurrent OME, Father: cochlear and vestibular hypoplasia, EVA, cup‐shaped pinnaeSon: HA, Grommets inserted for OME, myringoplasty to repair perforation, exploratory tympanotomy w/o reconstructionRecurrent OE from HA. Progressive loss over 23 years (29 audiograms), regression analysis was performed for air conduction and showed that progression was generally significant at all frequencies. However (after exclusion of the first audiogram), progression may have been nonlinear; the runs test was significant at 0.25 to 2 kHz in the left ear and at 0.25 kHz in the right ear. Progression in bone conduction thresholds was significant at 0.5 and 1 kHz in both ears and at 2 kHz in the left ear. Independently of age, the air‐bone gap in both ears was 30 to 60 dB at 0.5 to 1 kHz and under 40 dB at the higher frequencies. Thus, the air‐bone gap did not show any substantial progression, but it did show considerable fluctuation
23Bellini et al n = 10 (nine families)Mixed, conductive, SN<1 monthsxxLop‐ear deformityxx
24Stinckens et al n = 12 (two generations)SN1–35 yearsxProgressive, stableEVA, cochlear hypoplasiaxx
25Klingebiel et al n = 2SNxxxSC (superior) dysplasia, cochlear hypoplasia, EVA,xx
26Fukuda et al n = 5 (two generations)Mixed, SNxMild‐profoundxOMETympanotomy for effusionx
27Kemperman et al n = 35 (six families)Mixed, SNxxProgressive, fluctuantEES/D, cochlea and labyrinth hypoplasia, malformed auricles, fluid in ME, EAC atresiaB/L correction of malformed auricles (n = 3), myringoplasty (n = 1), Reconstruction of EAC atresia (n = 1)x
28Pierides et al n = 10 (two generations)xxVariableProgressiveEE malformations‐ asymmetric + cup‐shapedxx
29Ceruti et al n = 8 (two generations)SN5–39 yearsVariableProgressiveCochlear hypoplasia/dysplasia, B/L cochlear nerve hypoplasia, SC and OC malformations, EVA, EES/Dxx
30Yashima et al n = 3 (two families)Mixed, SN18–53 yearsMild–moderatexMild stapes deformity, EVA, common cavity of vestibule (B/L), cup shaped pinnaexx
31Kemperman et al n = 32 (six families)X16–79 yearsxProgressive, fluctuantEVA, cochlear hypoplasiaxx
32Propst et al n = 21X0.9–42.8 yearsxxCochlea hypoplasia (apical turn), medially deviated facial nerve, funnel‐shaped IAC, patulous eustachian tube, abnormal incus ligaments, malleoincudal anomaliesxx
33Rana et al n = 1X6 yearsxxPoorly pneumatized mastoids, partial agenesis of EAC (B/L), malformed (cupped) auricles (B/L)xx
34Kim et al n = 2 (two generations)Mixed3 and 30 yearsModerate profoundxEAC stenosis, poor pneumatisation and dense mass in the mastoid and ME cavity, cochlear hypoplasia, EVA, OC malformation, OM, bilateral cup‐shaped anteverted microtiaHA and auditory rehabilitationx
35Ito et al n = 1Mixed18 yearsModerateProgressiveEVA, enlarged vestibule, middle and inner ear malformationsxx
36Kameswaran et al n = 1SN3 yearsProfoundxSevere vestibular dysplasia, dilated SC and malformed ossicles (B/L), cup‐shaped ears, contracted mastoid antrumHA at 1 year, At 3 years CI: Nucleus 24 channel straight array was inserted and 19 electrodes, cochleostomy was sited more antero‐superior to the round windowNo intraoperative complications, good improvement with closed‐set speech recognition
37Dogru et al n = 1Mixed20 yeasrsModeratexIncreased mastoid pneumatization (B/L)xx
38Matsunaga et al n = 4 (three generations)Mixed31–65 yearsMild–severeStableEVA, cochlear hypoplasia, abnormal ossicles, enlarged vestibule, lop‐ear deformityHA from infancy, ossicular reconstructionManipulation within the tympanic cavity was suspended after difficulties, with failed improvement of hearing
39Sanggaard et al n = 17 (two families) a SNxMild–profoundProgressiveExternal, middle and inner ear anomalies (nonspecified)xx
40Garg et al n = 1x19 yearsProfoundxLow set, lop‐earsHAGood response
41Senel et al n = 2 (two generations)Mixed, conductive6 and 44 yearsMild–moderatexCochlear and SC hypoplasia, OC malformation, enlarged IAC (B/L), unilateral malleus and incus hypoplasiaOperations for hearing loss scheduled for both patientsx
42Ayçiçek et al n = 7 (three generations)Mixed, conductive, SN18–75 yearsxxProminent ear deformityxx
43Johnston et al n = 1Mixed12 monthsModerate–severexME dermoid cyst, displaced malleus, malformed ossicles, medially located and opacified ME space, funnel‐shaped EVA, defect in tympanic plateHA (B/L), Myringotomy with grommet insertion for bilateral OME, transmastoid and transcanal exploration of whitish mass

At 6 months, good healing and audiogram was unchanged (PTA showed R moderately to mild mixed loss, L profound‐severe loss). The patient was wearing binaural aids and participated in mixed signing and spoken English

44Bisanna et al n = 1SN16 yearsModerate–severeProgressiveCholesteatoma, partially destroyed malleus and incus, sclerotic mastoid, perforated TM, cup‐shaped pinnae, low set earCholesteatoma removed with radical mastoidectomyx
45Noguchi et al n = 1Mixed21 yearsModerateStableEVA (B/L)HAx
46Song et al n = 10 (seven families)Mixed1‐43 yearsModerate–severeProgressiveCochlear hypoplasia, EVA, dilated vestibule, facial nerve anomaly, malformed/misaligned/fused ossicles, IAC bulbous/funnelHA (n = 10), 3 ossiculoplasties s, 2 stapedotomies, 1 cholesteotoma removal with incus interposition, 2 CIAll ME surgeries were unsuccessful, 8/10 benefitted from HA, 2 who did not benefit went on to have successful outcomes with CI (hearing and language ability)
47Jankauskienè et al n = 1x4 daysxxxxx
48Lapeña et al n = 1x6 yearsModerate–severexxHA (B/L) at age 3 yearsx
49Castiglione et al n = 2Conductive9 and 30 yearsMildProgressiveMild auricular anomalies, normal otoscopy, hypoplastic/dysplastic SC, dilated/bulbous IAC, FN deviation, large mastoid emissary vein, dysplastic incus and hypoplastic long process, patulous Eustachian tube, hypoplastic/dysplastic cochleaNo intervention requiredx
50Jalil et al n = 1Conductive8 yearsxProgressiveOMEGrommets, HA and rehabilitationNo improvement with grommets
51Morisada et al n = 45Mixed, conductive, SNxxxEAC stenosis, pinnae deformitiesHA (n =?), surgical management including tympanoplasty, grommet insertion and CI (n = 11)80% success with HA, 64% (7/11) success with surgery
52Schmidt et al n = 1SN43 yearsxProgressiveEnlarged Eustachian tubes, absent mastoid cellsHA at age 3 yearsx
53Ječmenica et al n = 1Conductive4 yearsSeverexxHA for air conductionSubjective speech improvements, but intelligibility is still not satisfying
54Ginat et al n = 1Mixed50 yearsProfoundProgressiveExtensive ossicular anomalies (B/L), ectopic and dysmorphic right incudo‐malleal complex projecting into the middle cranial fossa, cochlear hypoplasia (B/L), malformed vestibules and SC (lateral and posterior), ICA canal hypoplasia, high‐riding jugular bulb up to the round window, dysmorphic IAC, anomalous positioning of the facial nerve canalsHA (B/L) from childhood, unilateral CI at 50 years, CI with compressed array of electrodes (round window approach)HA not sufficient, excellent subjective improvement with CI, no complications. Initial postoperative sound detection thresholds at 40 dB or less 250–2000 Hz and 50 dB or less for 4000–6000 Hz
55Unzaki et al n = 44Mixed, conductive, SN0–60 yearsxxInner, middle, external, and EAC anomalies (nonspecified)xx
56Nasir et al n = 1Mixed4 yearsSeverexxHA (B/L)x
57Hsu et al n = 9Mixed, conductive, SN1–14 yearsxxUnwound cochlear dysmorphology, funnel IAC, EVA, medialized facial nervexx
58Parkes et al n = 30x0.5–42.8 yearsxxAbnormally located/absent Koerner's septum (45%), severely hypoplastic/absent antrum (50%), dysplastic short process of incus (62%), dysplastic SC (73%)xx
59Wang et al n = 3 (one family)Mixed, conductivexxxME malformation (B/L), cochlear and SC (posterior) hypoplasia, OM (B/L), microtiaxx
60Chen at al n = 7 (two families, three generations)MixedxProfoundProgressiveCochlear hypoplasia, stenosis of cochlear nerve canal orifice, displaced and deformed ossicles, mastoid cells hypoplasiaxx
61Mironovich et al n = 8 (four families)Conductive, SN3–38 yearsMild–severexEVA + EES, cochlear hypoplasia, dysplastic SC, dilated IAC, ossicle malformations, protruding earsxx
62Men et al n = 3 (one family)xxProfoundxEVA, EES, MD, cochlear fusion, ME anomalies, cup shaped pinnae, low set ear1 CIEasy electrode implantation, no complications, Preoperatively, auditory brainstem response demonstrated bilateral profound hearing loss. At 4 months postimplantation, the patient had pure tone average of 55–70 dB in free‐field conditions and thresholds for Ling sounds of 55–70 dB at 6 months. Good progression in listening comprehension
63Li et al n = 1Mixed7 yearsModeratexAuricular anomalies (dysplasia, anterior auricular fistulas, auricular appendix), EAC stenosis, OM papillae, microtia, pinnae deformity, ankylotiaEAC formation, and tympanoplastySignificant improvement in hearing 1‐year postoperative. Preoperative hearing threshold: 56.25 (right) and 62.5 dB (left) hearing level in air conduction. Postoperative: 52.5 (right) and 25 dB (left)
64Xing et al n = 4 (three generations)Mixed1.5–51 yearsxStableCochlear hypoplasia (B/L), narrow EAC, ossicular dysplasia, microtia, auricular malformationBAHA for 2 casesGood response

Study reports six families, four of which are already included by Ostri and Gimsing.

Abbreviations: EAC, external auditory canal; EED, external ear deformity; EVA, enlarged ventricular aqueduct; IAC, internal auditory canal; MD, Meniere's disease; ME, middle ear; OC, ossicular chain; OME, otitis media with effusion; PTA, pure tone audiogram; SN, sensorineural hearing loss.

Summary of audiological outcomes, anatomical findings, and interventions At 6 months, good healing and audiogram was unchanged (PTA showed R moderately to mild mixed loss, L profound‐severe loss). The patient was wearing binaural aids and participated in mixed signing and spoken English Study reports six families, four of which are already included by Ostri and Gimsing. Abbreviations: EAC, external auditory canal; EED, external ear deformity; EVA, enlarged ventricular aqueduct; IAC, internal auditory canal; MD, Meniere's disease; ME, middle ear; OC, ossicular chain; OME, otitis media with effusion; PTA, pure tone audiogram; SN, sensorineural hearing loss.

BOR spectrum

A range of BOR symptoms were described, with 42 studies (66%) involving patients with renal manifestations , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , including renal hypoplasia , , , , , , , , or agenesis, , , , , , , , hydronephrosis, , , , , secondary arterial hypertension, mesangial cell glomerulitis, and renal failure of varying degrees. , , , , , , , , In 53 of the 64 studies, authors reported patients with preauricular pits, tags, clefts, or sinuses , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and in 47 studies, patients with branchial cleft abnormalities were described. , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Facial anomalies were described in several studies including dysmorphic features, , lacrimal anomalies, , , , , , , , , palatine malformations, , , , , , , , , hemifacial microsomia, , facial nerve paresis, , , prominent epicanthic folds, jaw anomalies, , , iris atrophy, and microdontia. Other clinical manifestations described included cardiac malformations, , , , developmental delay, , mental retardation. , hip dysplasia, osteosclerosis, imperforate anus, , intracranial hemorrhage, sloping shoulder deformity, diabetes mellitus, and epilepsy. ,

Anatomical and audiological findings

The key anatomical and audiological findings are summarized in Table 2. Inner ear malformations were described in 169 patients, 70 (41%) of which were detected to have linkage or mutations of the EYA1 gene. Middle ear anomalies were reported in 145 cases, including 48 (33%) patients with EYA1 linkage/mutations. External ear abnormalities were described in 151 patients, 87 (58%) of which had EYA1 mutations or linkage to the gene. The anatomical findings according to genetic status can be found in Figure 2.
FIGURE 2

. Ear anomalies according to genetics

. Ear anomalies according to genetics In the inner ear a variety of anomalies have been observed including cochlear hypoplasia , , , , , , , , , , , , , , , , , , , , , , , , , , or dysplasia, , , , , , , , Mondini deformity, , , hypoplastic , , , , , , , or abnormal , , , , , , semicircular canals, abnormal , , , or dilated vestibules, , , , , enlargement of the vestibular aqueduct, , , , , , , , , , , , , , , common cavity deformity of the vestibule, abnormalities of the internal auditory canal, , , , , , , , , , enlarged endolymphatic sacs and/or ducts, , , , , , cochlear nerve hypoplasia, and facial nerve abnormalities. , , , , , , In the middle ear, many studies reported fixed, , , , , , hypoplastic, , , , malformed, , , , , , , , , , , , , , , , , , , , , , , , or displaced ossicles. , , , , , , , , , In one study, three patients were found to have a massive ossicular chain with reduced middle ear space. An underdeveloped tympanic cavity was also described in two further studies, one of which was associated with an absent, oval window. , Other anomalies included cholesteatoma, , , , , otitis media , , , , , with effusion, , , , patulous Eustachian tube, , , and a middle ear dermoid cyst. Tympanic membrane perforations were reported by Bisanna et al.; however, Castiglione et al. and Millman et al. reported normal otoscopic examinations. , , In three studies, there was poor or absent pneumatization of the mastoid, , , with increased bilateral pneumatisation reported in one study. Other abnormalities included an absent Koerner's septum, hypoplastic, enlarged or absent antrum, , , tympanic plate defects, large mastoid emissary vein, sclerotic mastoid, and absent or hypoplastic mastoid cells. , External auditory canal anomalies and ankylotia , , , , , , , were reported alongside abnormal external ear appearances, , , , , , , including specific descriptions of cup‐shaped pinnae, , , , , , , , , , , , , , microtia, , , , , “lop,” , , , , low‐set, , , or protuberant ears. , Hearing loss was described in all 64 studies and were categorized in 308 patients. In 89 (29%) patients, sensorineural loss was reported, , , , , , , , , , , , , , , , , , , , , , , 62 (20%) had a conductive loss, , , , , , , , , , , , , , , , , , and 157 (51%) had a mixed type of hearing loss. , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , The reported degree, pattern, and onset were varied. The severity ranged from mild to profound, with 20 studies describing a progressive pattern , , , , , , , , , , , , , , , , , , , and 13 studies describing stable patterns of hearing loss. , , , , , , , , , , , , Where reported, the onset was predominantly from childhood; however, adult‐onset cases were also described.

Management of hearing loss

A summary of the interventions and reported outcomes can be found in Table 3. In 22 studies, patients were managed with hearing aids, with variable success. , , , , , , , , , , , , , , , , , , , , , In at least eight patients, hearing aids alone were successful when used in isolation. Surgical intervention was described in 28 studies, with details given for 58 operations. , , , , , , , , , , , , , , , , , , , , , , , , , These included exploratory tympanotomies, , , , , , , , , myringotomies with grommet insertion, , , , , , mastoidectomies, , , , ossicular reconstruction, , , , , , cholesteatoma removal, , , , , auricular surgery, , stapedectomies, stapedotomies, tympanoplasty with external auditory canal (EAC) formation, , myringoplasty, and bone‐anchored hearing aid (BAHA) insertion. Of the 30 middle ear procedures reporting postoperative outcomes, benefit was seen in only 11 cases. Successful operations included a mastoidectomy with creation of neo‐oval window resulting in significant hearing improvement at 2‐year follow‐up, an incus homograft prosthesis with improvement in air bone gap below 2000 Hz, and one patient undergoing an unspecified middle ear procedure with only a small improvement in air conduction threshold. When used in conjunction with hearing aids, acceptable auditory function was reported in one patient undergoing grommet insertion with radical mastoidectomy, and another with myringotomy (with grommets), plus canalplasty and atticotomy. Unsuccessful outcome were described in a number of ossicular reconstructions , , , , and myringotomies with grommet insertion. ,
TABLE 3

Summary of interventions and reported outcomes

Beneficial outcomeBeneficialNonbeneficial
HA alone8/13 Song: successful response from HA (n = 8/10), Morisada: 80% success with HA (n = 40/50) Fraser: HA with rehab unsuccessful (n = 1), Melnick: difficulty communicating (n = 1), Ginat: HA not sufficient (n = 1)
BAHA2/2 Xing: Good responsex
CI5/5 Kameswaran: No intraoperative complications, good improvement with closed‐set speech recognition (n = 1), Men: Easy electrode implantation, no complications, preoperatively, auditory brainstem response demonstrated bilateral profound hearing loss. At 4 months postimplantation, the patient had pure tone average of 55–70 dB in free‐field conditions and thresholds for Ling sounds of 55–70 dB at 6 months. Good progression in listening comprehension. Ginat: excellent subjective improvement with CI, Initial postoperative sound detection thresholds at 40 dB or less 250–2000 Hz and 50 dB or less for 4000–6000 Hz, no postoperative complications (n = 1), Song: Successful outcomes in hearing and language ability, with HA (n = 2), Morisada: 64% (7/11) success with surgery including CI (n = unclear)x
Middle ear surgery11/30

Cremers: Mastoidectomy with creation of neo‐oval window; significant hearing improvement at 2 years follow‐up (from 55 to 15 dB PTA air bone gap closure) (n = 1), Gimsing: Incus homograft prosthesis; improvement in air bone gap below 2000 Hz (n = 1), nonspecified middle ear surgery; air conduction threshold improved only 20 dB (n = 1), Morisada: 64% (7/11) success with surgery including grommet insertion and tympanoplasty (n = unclear), Li: EAC formation, and tympanoplasty—significant improvement in hearing 1‐year postoperative (preoperative hearing threshold: 56.25 (right) nd 62.5 dB (left) air conduction, postoperative:

52.5 (right) and 25 dB (left) (n = 1)

Fraser: unsuccessful stapedectomies (n = 4), Cremers: Teflon interposition unsuccessful (n = 3) not possible to attempt (n = 4), Graham: Poor postoperative healing after successful cholesteatoma removal (n = 1), Song: 3 ossiculoplasties, 2 stapedotomies, 1 cholesteatoma removal with incus interposition‐ all unsuccessful (n = 6), Slack: stapes reconstruction with interposed homograft incus between malleus handle and oval window, no improvement in hearing on PTA (figures not provided, n = 2)
HA + surgery2/6

Worley: Grommets inserted, radical mastoidectomy w/o reconstruction, stenting of stenosed meatus required; facial nerve function preserved postoperatively, manages well with HA (B/L). She attends a mainstream school with input from a teacher for the deaf (n = 1), Johnston: Myringotomy with grommet insertion for B/L OME, transmastoid and transcanal exploration of whitish mass with canalplasty,TM repair + atticotomy. At 6 month follow‐up: good healing, no change to audiogram (PTA showed R moderately to mild mixed loss, L profound–severe loss), using HA (B/L) with mixed signing and spoken English (n = 1)

Matsunaga: HA from infancy, ossicular reconstruction unsuccessful with failed improvement of hearing (n = 1), Kemperman: Grommets inserted for OME, myringoplasty to repair perforation—recurrent OE from HA. Progressive loss over 23 years (29 audiograms), regression analysis was performed for air conduction and showed that progression was generally significant at all frequencies. However (after exclusion of the first audiogram), progression may have been nonlinear; the runs test was significant at 0.25 to 2 kHz in the left ear and at 0.25 kHz in the right ear. Progression in bone conduction thresholds was significant at 0.5 and 1 kHz in both ears and at 2 kHz in the left ear. Independently of age, the air‐bone gap in both ears was 30 to 60 dB at 0.5 to 1 kHz and under 40 dB at the higher frequencies. Thus, the air‐bone gap did not show any substantial progression, but it did show considerable fluctuation. (n = 1), Jalil: Grommets, HA and rehabilitation—no improvement (n = 1).

Smith: myringotomies with B/L grommet insertion and ossicular reconstruction with total ossicular replacement prosthesis‐ persistent mild–moderate conductive loss, wears HA (n = 1)

Abbreviations: BAHA, bone‐anchored hearing aid; CI, cochlear implantation; HA, Hearing aid.

Summary of interventions and reported outcomes Cremers: Mastoidectomy with creation of neo‐oval window; significant hearing improvement at 2 years follow‐up (from 55 to 15 dB PTA air bone gap closure) (n = 1), Gimsing: Incus homograft prosthesis; improvement in air bone gap below 2000 Hz (n = 1), nonspecified middle ear surgery; air conduction threshold improved only 20 dB (n = 1), Morisada: 64% (7/11) success with surgery including grommet insertion and tympanoplasty (n = unclear), Li: EAC formation, and tympanoplasty—significant improvement in hearing 1‐year postoperative (preoperative hearing threshold: 56.25 (right) nd 62.5 dB (left) air conduction, postoperative: 52.5 (right) and 25 dB (left) (n = 1) Worley: Grommets inserted, radical mastoidectomy w/o reconstruction, stenting of stenosed meatus required; facial nerve function preserved postoperatively, manages well with HA (B/L). She attends a mainstream school with input from a teacher for the deaf (n = 1), Johnston: Myringotomy with grommet insertion for B/L OME, transmastoid and transcanal exploration of whitish mass with canalplasty,TM repair + atticotomy. At 6 month follow‐up: good healing, no change to audiogram (PTA showed R moderately to mild mixed loss, L profound–severe loss), using HA (B/L) with mixed signing and spoken English (n = 1) Matsunaga: HA from infancy, ossicular reconstruction unsuccessful with failed improvement of hearing (n = 1), Kemperman: Grommets inserted for OME, myringoplasty to repair perforation—recurrent OE from HA. Progressive loss over 23 years (29 audiograms), regression analysis was performed for air conduction and showed that progression was generally significant at all frequencies. However (after exclusion of the first audiogram), progression may have been nonlinear; the runs test was significant at 0.25 to 2 kHz in the left ear and at 0.25 kHz in the right ear. Progression in bone conduction thresholds was significant at 0.5 and 1 kHz in both ears and at 2 kHz in the left ear. Independently of age, the air‐bone gap in both ears was 30 to 60 dB at 0.5 to 1 kHz and under 40 dB at the higher frequencies. Thus, the air‐bone gap did not show any substantial progression, but it did show considerable fluctuation. (n = 1), Jalil: Grommets, HA and rehabilitation—no improvement (n = 1). Smith: myringotomies with B/L grommet insertion and ossicular reconstruction with total ossicular replacement prosthesis‐ persistent mild–moderate conductive loss, wears HA (n = 1) Abbreviations: BAHA, bone‐anchored hearing aid; CI, cochlear implantation; HA, Hearing aid. Cochlear implantation was reported in five studies, in at least six patients. Three studies were single case reports, , , Song et al. reported two patients, and Morisada et al. reported combined success in seven of 11 patients who underwent either CI, tympanoplasty, or grommet insertion. No further details regarding implantation were provided. The remaining four authors described a total of five cases who underwent CI, all of which had promising outcomes. Song et al. reported two adolescent patients with severe to profound mixed hearing loss who experienced significant improvements in hearing and language ability (no objective data) after unilateral implantation, one of which had failed to improve with ossiculoplasty. In both cases, computed tomography (CT) and magnetic resonance imaging (MRI) demonstrated bilateral dilated vestibule, enlarged vestibular aqueduct, ossicular anomalies, and bilaterally deviated facial nerves. A perilymphatic gusher was reported in one case; however, this was easily controlled by conventional methods. Ginat et al. also reported excellent subjective improvement in a 50‐year‐old gentleman who had a unilateral device implanted with a compressed array of electrodes, via round window approach. Initial postoperative sound detection thresholds were 40 dB or less for 250–2000 Hz and 50 dB or less for 4000–6000 Hz (no audiograms were recorded preoperatively). The patient was found to have extensive bilateral ossicular anomalies, malformed vestibules and semicircular canals, and bilateral cochlear hypoplasia with absent apical turns and J‐shaped middle turn. The patient was also noted to have malplaced facial nerve canals and a high‐riding jugular bulb up to the round window on the contralateral side. No postoperative complications were reported. Men et al. reported easy electrode implantation, with no complications in a patient with profound hearing loss, an enlarged vestibular aqueduct with enlarged endolymphatic sacs, Incomplete partition type II/Mondini cochlear and middle ear anomalies. Preoperatively, auditory brainstem response demonstrated bilateral profound hearing loss. At 4 months postimplantation, the patient had pure‐tone average of 55–70 dB and thresholds for Ling sounds of 55–70 dB at 6 months. The authors described good progression in listening comprehension and no aversion to loud sounds. Kameswaran et al. reported implantation with a Nucleus 24 channel straight aray, with and 19 electrodes successfully inserted in a 3‐year‐old with profound sensorineural hearing loss. Severe vestibular dysplasia, dilated semicircular canals, ossicular malformations and a contracted mastoid antrum were demonstrated on high‐resolution CT and MRI studies. There were no intraoperative complications; however, as the cochlea was rotated, the cochleostomy was sited more anterosuperior to the round window niche than usual. The device was switched on at 3 weeks postoperative with good initial mapping responses. The authors reported that the child was showing good improvement in closed‐set speech recognition while undergoing intensive auditory verbal rehabilitation.

Quality of studies

The methodological quality of included studies was modest, predominantly consisting of case reports and noncontrolled case series with a small number of patients. All studies were OCEBM grade IV and were conducted retrospectively. Heterogeneity of audiological outcomes precluded a meta‐analysis. There were also limitations in reporting of hearing loss type, onset, severity, and the interventions performed. The Risk of Bias table can be found in Table 4. Only nine studies reported objective outcomes for the interventions described. Pre and post PTA were used to assess audiological interventions in five studies. , , , , Smith et al. used speech reception thresholds and PTA to assess two patients with grommets and/or ossicular prosthesis and reconstruction. In one study (Ginat et al.) just post‐intervention PTA was recorded. Men et al. reported preimplantation auditory brainstem response and postoperative PTA (ling sounds). Kemperman et al. reported longitudinal changes (no direct preintervention and postintervention comparison).
TABLE 4

Tabular representation of Brazelli Risk of Bias Tool

123456789101112131415161718
Melnick et al1976YesNoNoYesNoNANoUnclearUnclearYesNoNoUnclearNoYesNAYesNA
Fraser et al1978YesNoNoYesNoNAYesUnclearUnclearYesNoNoUnclearNoYesNAYesNA
Cremers et al1980Yesnonoyesnon/ayesunclearunclearyesnonononoyesn/ayesn/a
Smith et al1984NoNoNoNoNoNAYesUnclearUnclearYesYesNoYesNoYesNAYesNA
Slack et al1985YesNoNoYesNoNAYesYesYesYesYesNoUnclearNoYesNAYesNA
Gimsing et al1986YesNoNoYesNoNANoYesYesYesYesNoUnclearNoYesNAYesNA
Lipkin et al1986NoNoYesNoNoNAYesUnclearUnclearYesNoNoNoNoYesNAYesNA
Martini et al1987NoNoNoUnclearNoNAYesUnclearUnclearNoNoNoNANoYesNAYesNA
Ostri et al1991YesNoNoYesNoNANoNANAYesNoNoNoNoYesNAYesNA
Dagglias et al1992NoNoNANANoNANoUnclearUnclearYesNoNoNoNoYesNAYesNA
Cremers et al1993NoNoNoUnclearNoNAYesYesYesYesYesNoYesNoYesNAYesNA
König et al1994NoNoYesYesNoNANANANANANANoNANoYesNAYesNA
Chen et al1995YesUnclearNoYesNoNANANANANANANoNANoYesNAYesNA
Millman et al1995NoNoNANANoNANANANANANANoNANoYesNAYesNA
Misra et al1998NoNoNANANoNANoUnclearUnclearNoNoNoNoNoYesNAYesNA
Graham et al1999NoNoNoYesNoNAYesUnclearUnclearYesNoNoNoNoYesNAYesNA
Weber et al1999NoNoNoYesNoNANANANANANANoNANoYesNAYesNA
Worley e tal1999NoNoNANANoNAYesYesYesYesNoNoYesNoYesNAYesNA
Prabhu et al1999NoNoNANANoNANANANANANANoNANoYesNAYesNA
Usami et al1999NoNoNoNoNoNANANANANANANoNANoYesNAYesNA
Bamiou et al2000YesYesYesYesNoNANANANANANANoNANoYesNANoNA
Kemperman et al2001NoNoNoYesNoNAYesUnclearUnclearYesYesNoYesNoYesNAYesNA
Bellini et al2001YesYesUnclearYesNoNANANANANANANoNANoYesNANoNA
Stinckens et al2001YesNoNoYesNoNANANANANANANoNANoYesNAYesNA
Klingebiel et al2001YesYesUnclearYesNoNANANANANANANoNANoYesNANoNA
Fukuda et al2001NoNoNoYesNoNAYesUnclearUnclearNoNoNoNoNoYesNAYesNA
Kemperman et al2002YesYesNoYesNoNAYesUnclearUnclearYesNoNoNoNoYesNANoNA
Pierides et al2002YesNoYesYesNoNANANANANANANoNANoYesNAYesNA
Ceruti et al2002YesYesYesYesYesNANANANANANANoNANoYesNAYesNA
Yashima et al2003NoNoNoYesNoNANANANANANANoNANoYesNAYesNA
Kemperman et al2004YesYesNoYesNoNANANANANANANoNANoYesNAYesNA
Propst et al2005YesYesUnclearYesNoNANANANANANANoNANoYesNANoNA
Rana et al2005NoNoNANANoNANANANANANANoNANoYesNAYesNA
Kim et al2005NoNonoYesNoNANANANANANANoNANoYesNAYesNA
Ito et al2006NoNoNANANoNANANANANANANoNANoYesNAYesNA
Kameswaran et al2007NoNoNANANoNAYesUnclearUnclearYesNoNoNoNoYesNAYesNA
Dogru et al2007NoNoNANANoNANANANANANoNANoYesNAYesNA
Matsunaga et al2007NoNoYesYesNoNAYesYesYesYesNoNoNoNoYesNAYesNA
Sanggaard et al2007YesNoNoYesNoNANANANANANANoNANoYesNAYesNA
Garg et al2008NoNoNANANoNAYesYesYesYesNoNoUnclearNoYesNAYesNA
Senel et al2009NoNoNoYesNoNANANANANANANoNANoYesNAYesNA
Ayçiçek et al2010NoNoYesYesNoNANANANANANANoNANoYesNANoNA
Johnston et al2011NoNoNANANoNAYesYesYesYesYesNoNoNoYesNAYesNA
Bisanna et al2011NoNoNANANoNAYesYesYesYesNoNoNoNoYesNAYesNA
Noguchi et al2011NoNoNANANoNAYesYesYesNoNoNoNoNoYesNAYesNA
Song et al2013YesYesNoYesNoNAYesUnclearUnclearYesNoNoUnclearNoYesNAYesNA
Jankauskienè et al2013NoNoNANANoNANANANANANANoNANoYesNANoNA
Lapeña et al2013NoNoNANANoNANANANANANANoNANoYesNANoNA
Castiglione et al2014YesYesNoYesNoNANANANANANANoNANoYesNAYesNA
Jalil et al2014NoNoNANANoNAYesYesYesYesNoNoNoNoYesNANoNA
Morisada et al2014YesYesYesYesNoNANoUnclearUnclearYesNoNoNoNoYesNANoNA
Schmidt et al2014NoNoNANANoNANANANANANANoNANoYesNANoNA
Ječmenica et al2015NoNoNANANoNAYesUnclearYesYesNoNoUnclearNoYesNANoNA
Ginat et al2016NoNoNANANoNAYesYesYesYesYesNoNoNoYesNAYesNA
Unzaki et al2018YesYesUnclearYesNoNANANANANANANoNANoYesNANoNA
Nasir et al2018NoNoNANANoNAYesNANANoNoNoNoNoYesNANoNA
Hsu et al2018YesYesUnclearYesNoNANANANAYesNANoNANoYesNAYesNA
Parkes et al2018YesYesUnclearYesNoNANANANAYesNANoNANoYesNAYesNA
Wang et al2018NoYesNoYesNoNANANANAYesNANoNANoYesNANoNA
Chen at al2019NoNoUnclearYesNoNANANANANANANoNANoYesNANoNA
Mironovich et al2019NoNoNoNoNoNANANANANANANoNANoYesNAYesNA
Men et al2020NoNoYesYesNoNAYesYesYesYesYesNoNoNoYesNAYesNA
Li et al2020NoNoNANANoNAYesUnclearYesYesYesNoYesNoYesNAYesNA
Xing et al2020NoNoNoYesNoNAYesUnclearUnclearYesNoNoUnclearNoYesNANoNA

Note: 1. Were participants a representative sample selected from a relevant patient population (e.g., randomly selected from those seeking treatment despite age, duration of disease, primary or secondary disease, and severity of disease)?, 2. Were the inclusion/exclusion criteria of participants clearly described?, 3. Were participants entering the study at a similar point in their disease progression (i.e., severity of disease)?, 4. Was selection of patients consecutive?, 5. Was data collection undertaken prospectively?, 6. Were the groups comparable on demographic characteristics and clinical features?, 7. Was the intervention (and comparison) clearly defined?, 8. Was the intervention undertaken by someone experienced at performing the procedure? (“Yes” if the practitioner received training on conducting the procedure before or conducted same kind of procedure before [i.e., no learning curve].), 9. Were the staff, place, and facilities where the patients were treated appropriate for performing the procedure (e.g., access to back‐up facilities in hospital or special clinic)?, 10. Were any of the important outcomes considered (i.e., on clinical effectiveness, cost‐effectiveness, or learning curves)?, 11. Were objective (valid and reliable) outcome measures used, including satisfaction scale?, 12. Was the assessment of main outcomes blind?, 13. Was follow‐up long enough (≥1 year) to detect important effects on outcomes of interest?, 14. Was information provided on nonrespondents, dropouts? (“No” if participants were those whose follow‐up records were available [retrospective].), 15. Were the characteristics of withdrawals/dropouts similar to those that completed the study and therefore unlikely to cause bias? (“Yes” if no withdrawal/dropout; “No” if dropout rate ≥30% or differential dropout), 16. Was length of follow‐up similar between comparison groups?, 17. Were the important prognostic factors identified (e.g., age, duration of disease, and disease severity)? (“Yes” if two or more than two factors were identified.), 18. Were the analyses adjusted for confounding factors?

Tabular representation of Brazelli Risk of Bias Tool Note: 1. Were participants a representative sample selected from a relevant patient population (e.g., randomly selected from those seeking treatment despite age, duration of disease, primary or secondary disease, and severity of disease)?, 2. Were the inclusion/exclusion criteria of participants clearly described?, 3. Were participants entering the study at a similar point in their disease progression (i.e., severity of disease)?, 4. Was selection of patients consecutive?, 5. Was data collection undertaken prospectively?, 6. Were the groups comparable on demographic characteristics and clinical features?, 7. Was the intervention (and comparison) clearly defined?, 8. Was the intervention undertaken by someone experienced at performing the procedure? (“Yes” if the practitioner received training on conducting the procedure before or conducted same kind of procedure before [i.e., no learning curve].), 9. Were the staff, place, and facilities where the patients were treated appropriate for performing the procedure (e.g., access to back‐up facilities in hospital or special clinic)?, 10. Were any of the important outcomes considered (i.e., on clinical effectiveness, cost‐effectiveness, or learning curves)?, 11. Were objective (valid and reliable) outcome measures used, including satisfaction scale?, 12. Was the assessment of main outcomes blind?, 13. Was follow‐up long enough (≥1 year) to detect important effects on outcomes of interest?, 14. Was information provided on nonrespondents, dropouts? (“No” if participants were those whose follow‐up records were available [retrospective].), 15. Were the characteristics of withdrawals/dropouts similar to those that completed the study and therefore unlikely to cause bias? (“Yes” if no withdrawal/dropout; “No” if dropout rate ≥30% or differential dropout), 16. Was length of follow‐up similar between comparison groups?, 17. Were the important prognostic factors identified (e.g., age, duration of disease, and disease severity)? (“Yes” if two or more than two factors were identified.), 18. Were the analyses adjusted for confounding factors? Cremers co‐authored seven studies, including five from The Netherlands and two from Belgium. , , , , , , A crossover of authorship was also seen in six Japanese studies, , , , , , and a further two studies from Japan. , It is therefore possible that there may be some duplication of included patients. Sanggaard et al. reported on six Danish families, four of which had already been reported by Gimsing et al. and Ostri et al. Similarly, Kemperman et al. reported on six families over three studies. , , In these instances, patient numbers have only been included once in the final totals and for calculating percentage data.

DISCUSSION

The aim of this systematic review and narrative synthesis was to report audiometric outcomes in patients with BO/BOR undergoing ear surgery, or other forms of hearing rehabilitation. We successfully identified all the relevant literature, however the conclusions drawn from the literature are limited by the quality of evidence available. This review reports on the outcomes of anatomical and audiological profiles of patients with BOR/BO syndrome, reporting on an additional 30 studies to the previously published review by Lindau et al. Casazza and Meier's review of syndromic hearing loss demonstrated mild‐to‐profound hearing loss to occur in 70%–93% of reported BOR cases. In accordance with Lindau et al.’s findings, we found mixed hearing loss to be the most common type reported, with wide variability in pattern and severity. Huang et al. reported the loss of hearing from childhood to early adulthood. In our review, onset ranged from birth to middle age, demonstrating further variability. It is well documented in the literature that a wide variety of inner, middle, and external ear anomalies may present in BOR syndrome , . Many of the anatomical variations identified in our review are also features of other causes of syndromic hearing loss including oculoauriculovertebral dysplasia spectrum, Klippel Feil syndrome, Pierre Robin sequence, and CHARGE syndrome. In particular, Pendred syndrome shares many anatomical features; commonly presenting with progressive, fluctuant hearing loss, an enlarged vestibular aqueduct, cochlear hypoplasia, and enlarged endolymphatic ducts. Cochlear abnormalities were among the most commonly reported anatomical changes, with hypoplasia of the apical turn described in 100% of patients with BOR syndrome in two studies. , Hsu and colleagues identified the presence of an “unwound cochlea” as diagnostic marker for BOR, with 89% sensitivity and 100% specificity. On CT images, the authors describe the dysmorphology as an anteromedial rotation and displacement of the middle and apical turns of the cochlea away from the basal turn. This cochlear abnormality was previously described in patients with BOR syndrome by Robson. Furthermore, the medialization of the facial nerve to the cochlea was described in 78%–100% of BOR syndrome patients but 0% of those with other causes of hearing loss. , Given the varied phenotype and genotype, the identification of these features may provide a useful tool in the diagnosis of BO/BOR syndrome. CT scanning is a routine investigation at many hearing loss centers; however, with concerns regarding radiation exposure for young children, some otology departments are moving toward MR imaging. Ceruti et al. reported superior imaging with the use of MRI for visualizing the inner ear in patients with BOR. Enlargement of the endolymphatic sacs and ducts (which were not seen on CT) were visualized on MRI. Hypoplasia of the cochlear nerve was also seen in one patient, which could not be detected on CT. The majority of studies of anatomical variance in BOR syndrome have been investigated using temporal bone CT; therefore, further studies on the identification of diagnostic markers for BOR syndrome on MRI are required. Several studies have researched trends in phenotypic presentation of BOR syndrome. Sanggaard et al. reported Danish families with SIX1 mutations were observed to have fewer temporal bone malformations compared to those families with EYA1 mutations. Furthermore, two Japanese studies reported isolated unilateral EVA in two unrelated patients with SIX1 mutation. Both patients presented with nonprogressive mixed hearing loss with no renal anomalies. , Conversely, Kemperman et al. found an association between EVA and progressive, fluctuant sensorineural type of hearing loss. Molecular genetic testing can confirm the diagnosis, allow accurate genetic counseling and provide families with information on recurrence risks. However, due to the variable expressivity, severity of the phenotypic presentation is not possible, even when the mutation is identified. Given the lack of association between phenotype and genotype, several authors have suggested clinical or radiological criteria to stratify patients for genetic testing. Similarly Sanggaard et al. recommended genetic testing in clinically suspicious cases. It is also relevant to note, Chang et al. estimated that single‐stranded conformation polymorphism (SSCP)‐based genetic screening can identify EYA1 mutations in approximately 30% of those fulfilling their clinical criteria (Table 1); however, up to one‐fifth of EYA1 mutations represent complex genomic rearrangements and would not be detected by this method. More recently, Unzaki et al. used direct sequencing, multiplex ligation‐dependent probe amplification (MLPA), array‐based comparative genomic hybridization (aCGH), and next‐generation sequencing (NGS) to identify causative genes in 38 of 51 patients. As more effective sequencing methods become available with technological advancements, the link between genotype and phenotype may become more apparent. To further our scientific understanding, the prospective accumulation of genetic data is advised to refine the underlying pathophysiology, disease variability, and prognosis. The effectiveness of hearing aids reported in the included studies was varied. Morisada et al. conducted a national surveillance survey of patients with BOR in Japan with 80.1% of subjects reporting successful treatment with hearing aids. Subjective success with hearing aids alone was also described in two studies, , and postoperatively in a further two studies. , In addition, Xing et al. reported good responses in two patients with inner and middle ear anomalies who underwent BAHA surgery. Studies of adult hearing‐aid users found better speech intelligibility to be associated with younger age, increased working memory capacity and milder hearing loss. , In our review, unsuccessful use was described in seven studies with severity ranging from mild to profound in both adults and children. , , , , , , Many patients had substantial hearing loss, which was outside of the decibel range where one can expect satisfactory results with conventional hearing aids. A range of surgical interventions were described in our review. Despite being commonly reported, external ear malformations were managed surgically in only three studies. , , Six studies reported unsuccessful middle ear operations , , , , , ; however, significant audiological improvement was seen with ossicular reconstruction, and with the creation of a neo‐oval window during mastoidectomy. This technique has previously been described with success by Plester. Improvements were also reported one‐year postoperatively in a child undergoing EAC reconstruction and tympanoplasty. In a total of 64 studies, CI was only clearly described in five patients. Beneficial responses were reported in all five patients; however, the studies lacked formal audiological assessment and postoperative follow‐up. , , , Subjective improvement was reported by Song et al., Kameswaran et al., and Ginat et al. Men et al. reported a pure‐tone average of 55 to 70 dB under free‐field conditions at 4 months (compared to profound hearing loss on auditory brainstem response preoperatively), and Ginat et al. reported initial postimplantation thresholds at 40 dB (250–2000 Hz) and 50 dB (4000–6000) but provided no preoperative comparison. In terms of surgery, Parkes et al. reported extensive bony dysplasia in BOR mastoids, which given their importance as landmarks, may pose as an obstacle for CI. Kameswaran et al. reported a challenging operation with cochleostomy sited more anterosuperior to the round window in patient with a contracted mastoid antrum. No other mastoid anomalies were reported in the implanted patients; however, extensive cochlear, vestibular, and ossicular malformations were observed alongside deviation of the facial nerve. In a case series conducted by Palomeque Vera et al., all five patients with inner ear malformations (including cochlear hypoplasia), benefitted from CI; however, those with major malformations had worse audiological outcomes. Successful implantation has also been reported in patients with EVA, a feature noted in three patients receiving implants. Intraoperatively, one perilymphatic gush was described in a patient with EVA, a malformation associated with the release of cerebrospinal fluid upon cochleostomy. No other intraoperative events were described in the remaining studies, with easy insertion described by Men et al. and Ginat et al. , Given the potential intraoperative disorientation, CT in the preoperative period is recommended and can be used to estimate the potential depth if electrode insertion in the presence of cochlear hypoplasia. , Decision‐making surrounding hearing rehabilitation in patients with BOR is extremely complex, given the variation in phenotypes, and should be considered on a case‐by‐case basis. As with most hearing rehabilitation, management should be considered as a stepwise approach with more conservative measures, such as HAs, used initially if indicated. Surgery does have a role; however, surgical planning (including temporal bone imaging) is key and the consent process should reflect this complexity, including the potential for suboptimal or adverse outcomes. Preoperative counseling and involvement of the multidisciplinary team (including audiologists and pediatrics) are vital. The main limitation of this review regards the quality of the individual studies, with the majority being case series or single‐case reports with a lack of objective outcomes. Due to the heterogeneity in reporting, there were missing data values across the articles, including a lack of genetic information. It was not possible to conduct a meta‐analysis. Many studies also failed to report the audiological outcomes of hearing loss management, which would have been useful in assessing the appropriateness of different surgical or rehabilitation approaches. Without objective data, it remains difficult to provide reliable recommendations.

CONCLUSIONS

The range of audiological and anatomical variations in BO/BOR patients with hearing loss is extensive. Hearing loss is most commonly of a mixed type; however, considerable cases reported conductive or sensorineural loss. Impairment can be mild to profound, stable, or progressive and may present from birth up to adulthood. Considerable malformations were reported in the inner, middle, and outer ears, particularly the cochlear, ossicles, and auricles. Our review focused on hearing outcomes and ear anatomy; however, it is of note than a wide range of additional features were reported. Given the variable phenotypic presentation, it is possible that many BO/BOR patients are underdiagnosed. Patients presenting to otolaryngology departments for audiological work‐up should be examined other syndromic features, including preauricular or branchial sinuses, prompting renal investigations. The use of hearing aids was of uncertain benefit, with surgical intervention required in a significant number of cases. Limited success was reported with middle ear operations however all five patients receiving cochlear implants subjectively reported some benefit. In view of the anatomical landmarks, prior radiological investigation is imperative in surgical planning.

Summary of impact

This review provides an up‐to‐date, comprehensive review of BO/BOR syndrome to summarize the reported audiological and anatomical presentations. Surgical intervention has been poorly reported, with varying success. Given the wide variety in phenotypic features, we highlight the importance of careful clinical and radiological assessment when prior to surgery.

CONFLICT OF INTEREST

The authors declare no conflict of interest.
  86 in total

1.  Congenital cholesteatoma and malformations of the facial nerve: rare manifestations of the BOR syndrome.

Authors:  G E Graham; J E Allanson
Journal:  Am J Med Genet       Date:  1999-09-03

2.  The presence of a widened vestibular aqueduct and progressive sensorineural hearing loss in the branchio-oto-renal syndrome. A family study.

Authors:  C Stinckens; L Standaert; J W Casselman; P L Huygen; S Kumar; J Van de Wallen; C W Cremers
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2001-07-02       Impact factor: 1.675

3.  Branchio-Oto-renal syndrome: a report on nine family groups.

Authors:  C Bellini; G Piaggio; D Massocco; F Perfumo; R Gusmano; G Serra
Journal:  Am J Kidney Dis       Date:  2001-03       Impact factor: 8.860

4.  Anatomic and Quantitative Temporal Bone CT for Preoperative Assessment of Branchio-Oto-Renal Syndrome.

Authors:  D T Ginat; L Ferro; M B Gluth
Journal:  Clin Neuroradiol       Date:  2016-02-11       Impact factor: 3.649

Review 5.  Bilateral congenital cholesteatoma in branchio-oto-renal syndrome.

Authors:  G A Worley; A Vats; J Harcourt; D M Albert
Journal:  J Laryngol Otol       Date:  1999-09       Impact factor: 1.469

6.  Mitral valve prolapse as a new finding in branchio-oto-renal syndrome.

Authors:  Abdullah Ayçiçek; Hayrettin Sağlam; Cevdet Uğur Koçoğullari; Nurten Turhan Haktanir; Fevzi Sefa Dereköy; Mustafa Solak
Journal:  Clin Dysmorphol       Date:  2010-10       Impact factor: 0.816

7.  Identification of a Novel CNV at 8q13 in a Family With Branchio-Oto-Renal Syndrome and Epilepsy.

Authors:  Meichao Men; Wu Li; Hongsheng Chen; Jiayu Wu; Yong Feng; Hui Guo; Jia-Da Li
Journal:  Laryngoscope       Date:  2019-03-25       Impact factor: 3.325

8.  Temporal bone anomalies in the branchio-oto-renal syndrome: detailed computed tomographic and magnetic resonance imaging findings.

Authors:  S Ceruti; C Stinckens; C W R J Cremers; J W Casselman
Journal:  Otol Neurotol       Date:  2002-03       Impact factor: 2.311

9.  Congenital unilateral facial nerve palsy as an unusual presentation of BOR syndrome.

Authors:  Augustina Jankauskienė; Karolis Azukaitis
Journal:  Eur J Pediatr       Date:  2012-07-27       Impact factor: 3.183

10.  Non-inherited manifestation of bilateral branchial fistulae, bilateral pre-auricular sinuses and bilateral hearing loss: A variant of branchio-oto-renal syndrome.

Authors:  Indu Rana; Rajiv Dhawan; Sanjay Gudwani; Rajendra Bothra; N N Mathur
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2005-01
View more
  1 in total

Review 1.  Anatomical and audiological considerations in branchiootorenal syndrome: A systematic review.

Authors:  Kirsty Biggs; Gemma Crundwell; Christopher Metcalfe; Jameel Muzaffar; Peter Monksfield; Manohar Bance
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-02-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.